CStone Pharmaceuticals Eulerpool News

CStone Pharmaceuticals Eulerpool News

CStone Pharmaceuticals Notizie Azioni

CStone Pharmaceuticals è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie CStone Pharmaceuticals.

• 30 settembre ·

  Yahoo
  High Growth Tech Stocks In Hong Kong To Watch This September 2024
• 2 settembre ·

  Yahoo
  High Growth Tech Stocks In Hong Kong Featuring SUNeVision Holdings And Two Others
• 23 agosto ·

  Yahoo
  CStone Reports 2024 Interim Results and Recent Corporate Updates
• 26 luglio ·

  Yahoo
  CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer
• 2 giugno ·

  SeekingAlpha
  Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership
• 2 giugno ·

  Yahoo
  CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
• 26 maggio ·

  SeekingAlpha
  Week In Review: Hengrui And Dearon Announce $7.2B In Drug Licensings
• 24 maggio ·

  Yahoo
  CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website
• 27 marzo ·

  Yahoo
  CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
• 15 marzo ·

  Yahoo
  CStone Announces the Fifth Indication Approved for Sugemalimab in China as First-Line Treatment for Gastric Cancer